HENC (Hero Technologies) ROCE %: -3,051.85% (As of Sep. 2023)


What is Hero Technologies ROCE %?

Hero Technologies HENC ROCE % is -3,051.85% as of Sep. 2023.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hero Technologies's annualized ROCE % for the quarter that ended in Sep. 2023 was -3,051.85%.

Hero Technologies  (OTCPK:HENC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hero Technologies ROCE % Related Terms

Hero Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for Hero Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hero Technologies ROCE % Chart

Hero Technologies Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec20 Dec21 Dec22
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.02 -0.02 -93.55 0.00 0.00

Hero Technologies Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Mar18 Jun18 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -3,051.85

Hero Technologies ROCE % Calculation

Hero Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=-0.507/( ( (0.187 - 0.202) + (0.645 - 0.836) )/ 2 )
=-0.507/( (-0.015+-0.191)/ 2 )
=-0.507/-0.103
=492.23 %

Hero Technologies's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=-1.648/( ( (0.164 - 0.1) + (0.144 - 0.1) )/ 2 )
=-1.648/( ( 0.064 + 0.044 )/ 2 )
=-1.648/0.054
=-3,051.85 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -3,051.85% mean?
Hero Technologies (HENC) has a ROCE % of -3,051.85% as of Sep. 2023.
Is Hero Technologies' ROCE % too high?
Hero Technologies' current ROCE % is -3,051.85%.
How does Hero Technologies' ROCE % compare to ECGS and CPHI?
Hero Technologies' ROCE % of -3,051.85% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hero Technologies's current ROCE % is -3,051.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hero Technologies stock overvalued right now?
Hero Technologies (HENC) has a current ROCE % of -3,051.85%. The current ROCE % is -3,051.85%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Hero Technologies (HENC), the current ROCE % is -3,051.85% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hero Technologies Business Description

Address 8 The Green, Suite 4000, Dover, DE, USA, 19901
Hero Technologies Inc is a cannabis company with a vertically integrated business model and plan that includes cannabis genetic engineering, farmland for medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, retail operations, and dispensaries. It focuses on two principal segments of the cannabis industry, cultivation, and the dispensary business model, including combinations.